Posted on 23 December 2014
Tags: Eli Lilly, partnering, pharma partners
Eli, Lilly and Company pharma partners on a five-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with type 2 diabetes, which affects about 95 percent of those with the disease. Read the full story
Posted on 09 December 2014
Tags: big pharma, Eli Lilly, partnering, pharma partners
Eli Lilly and Company, Anthem, Inc. and HealthCore pharma partners for a five-year, real-world evidence research collaboration intended to improve health outcomes for patients. Read the full story
Posted on 30 October 2014
Tags: Astellas, big biotech, partnering, pharma partners
QIAGEN announced a biotech partnership agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. Read the full story
Posted on 29 October 2014
Tags: big pharma, pharma alliances, pharma deals, pharma partners
Triphase Accelerator announced a new strategic pharma deal with Celgene. Read the full story
Posted on 29 October 2014
Tags: big biotech, big pharma, pharma partners, Roche
Molecular Devices has partnered with the Discovery Technologies team at the Roche announced a biotech partnership to develop a high-throughput detection system for drug discovery screens employing Roche's proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF) assays. Read the full story
Posted on 27 October 2014
Tags: Bayer, big pharma, partnering, pharma, pharma partners
Bayer HealthCare and Kyoto University’s Office of Society-Academia Collaboration for Innovation pharma partners by signing a two-year agreement to jointly identify candidates for possible collaborative research projects. Read the full story
Posted on 21 October 2014
Tags: partnering, pharma licensing, pharma partners
Forendo Pharma has entered into a definitive pharma licensing deal for the US development and commercialization rights for fispemifene to Apricus Biosciences. Read the full story
Posted on 17 October 2014
Tags: pharma deals, pharma partnering, pharma partners, Roche
Cardiorentis announced a pharma partnership with Roche to establish the therapeutic efficacy and safety of Ularitide. Read the full story
Posted on 16 October 2014
Tags: big pharma, pharma alliances, pharma partnering, pharma partners, Sanofi
Selecta Biosciences JDRF have extended their pharma partnership and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. Read the full story
Posted on 14 October 2014
Tags: big pharma, GSK, pharma alliances, pharma partners
The University of Texas MD Anderson Cancer Center announced it formed a research alliance with GlaxoSmithKline to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer. Read the full story